Most Recent
Pharmaceutical companies Sanofi and Bristol-Myers Squibb are liable for losses to the federal government for excess subsidies it allegedly paid for the blood-thinner Plavix after an unjustified court injunction prevented the release of a generic version of the top-selling drug, an appeals court has heard.
The High Court won't wade into Kraft-Heinz's intellectual property dispute with Bega after the US food giant came up short twice its battle over the right to use its peanut butter trade dress in Australia.
The High Court has declined to weigh in on the patentability of software, rejecting e-commerce company Rokt's bid for review of a decision striking down its marketing invention.
The Full Federal Court has rejected a patent application for a digital advertising system by e-commerce firm Rokt in a test case by IP Australia that comes as a blow to the patentability of computer software in Australia.
US food giant Kraft-Heinz wants the High Court to hear its intellectual property stoush with Bega after twice losing the battle over the right to use its peanut butter trade dress in Australia.
A court has dismissed a claim by the Australian Government for $325 million against pharmaceutical companies Sanofi and Bristol-Myers Squibb allegedly owed for excess subsidies it paid for blood-thinner Plavix as a result of an interlocutory injunction blocking a generic version of the blockbuster drug.
Kraft has lost an appeal in its high-stakes legal battle against Bega over the right to use its distinctive peanut butter trade dress in Australia.
A landmark ruling granting fintech Rokt's application for a software patent has come under attack before the Full Federal Court, with the judges expressing skepticism about the invention's patentability.
The judge presiding over jostling shareholder class actions against logistics software company GetSwift suggested on Tuesday a "bill of peace" to join the actions, but lawyers leading the competing cases warned of the "economic hazard" of a merger.